NO922671L - Hirudinanalog, fremgangsmaate for fremstilling derav, antikoagulantpreparat, sekresjonsvektor, transformerte mikroorganismer som inneholder vektoren, og fremgangsmaate for fremstilling av produkter fra mikroorganismen - Google Patents

Hirudinanalog, fremgangsmaate for fremstilling derav, antikoagulantpreparat, sekresjonsvektor, transformerte mikroorganismer som inneholder vektoren, og fremgangsmaate for fremstilling av produkter fra mikroorganismen

Info

Publication number
NO922671L
NO922671L NO92922671A NO922671A NO922671L NO 922671 L NO922671 L NO 922671L NO 92922671 A NO92922671 A NO 92922671A NO 922671 A NO922671 A NO 922671A NO 922671 L NO922671 L NO 922671L
Authority
NO
Norway
Prior art keywords
vector
procedure
hirudin
secretary
organization
Prior art date
Application number
NO92922671A
Other languages
English (en)
Other versions
NO303735B1 (no
NO922671D0 (no
Inventor
Satoru Misawa
Hitoshi Matsuda
Yoshifumi Inoue
Hideyuki Furuya
Original Assignee
Nippon Mining Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2303096A external-priority patent/JPH07119237B2/ja
Priority claimed from JP4127191A external-priority patent/JP3226289B2/ja
Application filed by Nippon Mining Co filed Critical Nippon Mining Co
Publication of NO922671D0 publication Critical patent/NO922671D0/no
Publication of NO922671L publication Critical patent/NO922671L/no
Publication of NO303735B1 publication Critical patent/NO303735B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
NO922671A 1990-11-08 1992-07-07 Fremgangsmöte for fremstilling av en hirudinanalog, samt DNA-sekvens, sekresjonsvektor og transformerte mikroorganismer som inneholder vektoren NO303735B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2303096A JPH07119237B2 (ja) 1990-11-08 1990-11-08 ヒルジン変異体，その製造法及び抗凝血剤
JP4127191A JP3226289B2 (ja) 1991-02-13 1991-02-13 分泌ベクター、該ベクターで形質転換した微生物及び該微生物から産生される産物の製造法
PCT/JP1991/001533 WO1992008736A1 (fr) 1990-11-08 1991-11-08 Mutant d'hirudine, sa production, anticoagulant, vecteur secretoire, microorganisme transforme par ledit vecteur et production d'un produit a partir dudit microorganisme

Publications (3)

Publication Number Publication Date
NO922671D0 NO922671D0 (no) 1992-07-07
NO922671L true NO922671L (no) 1992-09-07
NO303735B1 NO303735B1 (no) 1998-08-24

Family

ID=26380836

Family Applications (2)

Application Number Title Priority Date Filing Date
NO922671A NO303735B1 (no) 1990-11-08 1992-07-07 Fremgangsmöte for fremstilling av en hirudinanalog, samt DNA-sekvens, sekresjonsvektor og transformerte mikroorganismer som inneholder vektoren
NO982207A NO982207D0 (no) 1990-11-08 1998-05-14 Fremmedproteinsekresjonsvektorer, transformerte mikroorganismer og fremgangsmÕte for fremstilling av hirudiner

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO982207A NO982207D0 (no) 1990-11-08 1998-05-14 Fremmedproteinsekresjonsvektorer, transformerte mikroorganismer og fremgangsmÕte for fremstilling av hirudiner

Country Status (12)

Country Link
US (2) US5516656A (no)
EP (2) EP0687731B1 (no)
AT (2) ATE176500T1 (no)
AU (2) AU648124B2 (no)
CA (2) CA2072375C (no)
DE (2) DE69121192T2 (no)
DK (2) DK0687731T3 (no)
ES (2) ES2129749T3 (no)
FI (1) FI107928B (no)
GR (2) GR3021410T3 (no)
NO (2) NO303735B1 (no)
WO (1) WO1992008736A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341414C (fr) * 1984-03-27 2002-12-31 Paul Tolstoshev Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
US5972648A (en) * 1993-09-28 1999-10-26 Japan Energy Corporation Hirudin analogs, methods of manufacture thereof and anticoagulant compositions having these as active ingredients
EP1231274A3 (en) * 1994-11-21 2002-10-09 The University Of Leeds Modified porteinase inhibitors
DE19944870A1 (de) * 1999-09-18 2001-03-29 Aventis Pharma Gmbh Signalsequenzen zur Herstellung von Leu-Hirudin über Sekretion durch E. coli in das Kulturmedium
US7202059B2 (en) 2001-02-20 2007-04-10 Sanofi-Aventis Deutschland Gmbh Fusion proteins capable of being secreted into a fermentation medium
US7638618B2 (en) 2001-02-20 2009-12-29 Sanofi-Aventis Deutschland Gmbh Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
DE10108211A1 (de) * 2001-02-20 2002-08-22 Aventis Pharma Gmbh Verwendung von Fusionsproteinen, deren N-terminaler Anteil aus einem Hirudinderivat besteht, zur Herstellung rekombinanter Proteine über Sekretion durch Hefen
DE10108212A1 (de) * 2001-02-20 2002-08-22 Aventis Pharma Gmbh Fusionsprotein zur Sekretion von Wertprotein in bakterielle Überstände
KR100447530B1 (ko) * 2001-08-14 2004-09-08 한국과학기술원 ＯｍｐＦ를 이용하여 목적 단백질을 대장균 세포외로분비생산하는 방법
AU2003262891B2 (en) * 2002-08-23 2008-11-13 E.I. Du Pont De Nemours And Company Utilization of starch products for biological production by fermentation
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および／または線溶系酵素阻害剤との組み合わせからなる医薬
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
PT1737889E (pt) 2004-10-19 2010-12-13 Lonza Ag Método para síntese de péptidos em fase sólida
DE502006009060D1 (de) * 2006-09-22 2011-04-21 Wacker Chemie Ag Verfahren zur fermentativen Herstellung von Antikörpern
CN101372512B (zh) * 2007-08-23 2011-03-23 中国人民解放军军事医学科学院生物工程研究所 一类抗凝血多肽及其用途
WO2010054503A1 (zh) * 2008-11-17 2010-05-20 中国人民解放军军事医学科学院生物工程研究所 抗凝血多肽及其应用
CN115572329B (zh) * 2021-06-21 2024-02-06 王大勇 一组活性增强代谢较慢的菲牛蛭基因重组水蛭素及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2562088B1 (fr) * 1984-03-27 1987-11-13 Transgene Sa Vecteurs d'expression de l'hirudine, cellules transformees et procede de preparation de l'hirudine
EP0177343B1 (en) * 1984-10-05 1992-07-22 Genentech, Inc. Dna, cell cultures and methods for the secretion of heterologous proteins and periplasmic protein recovery
DE3445532A1 (de) * 1984-12-13 1986-06-19 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Hirudin-pa, desulfatohirudine-pa, verfahren zur herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
DE3506992A1 (de) * 1985-02-27 1986-08-28 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
FR2607517B2 (fr) * 1986-12-01 1989-12-22 Transgene Sa Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu
US5084384A (en) * 1987-04-23 1992-01-28 Monsanto Company Secretion of insulin-like growth factor-I
JP2518862B2 (ja) * 1987-08-31 1996-07-31 株式会社蛋白工学研究所 新規プラスミドベクタ―
AU604925B2 (en) * 1988-02-23 1991-01-03 Schering Aktiengesellschaft A hirudin derivative
AU614121B2 (en) 1988-05-04 1991-08-22 Novartis Ag Improvements in the production of polypeptides
DE58907266T2 (de) * 1988-06-11 1994-09-29 Ciba Geigy Ag Polypeptide mit einer die Koagulierung hemmenden Wirkung.
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
JPH0227993A (ja) * 1988-07-15 1990-01-30 Nippon Shinyaku Co Ltd ｈＥＧＦの製法
JPH0648988B2 (ja) * 1988-07-26 1994-06-29 工業技術院長 トロンビン阻害物質の製造法
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
JPH0292288A (ja) * 1988-09-30 1990-04-03 Japan Tobacco Inc アクアライシンｉ前駆体をコードする遺伝子、それを含む発現ベクター、該発現ベクターを含む大腸菌及びそれを用いたアクアライシンｉの製造方法
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
JPH03164184A (ja) 1989-08-10 1991-07-16 Nippon Mining Co Ltd ヒルジン発現ベクター、ヒルジン融合蛋白、形質転換微生物及びヒルジンの製造法
PT94949A (pt) * 1989-08-10 1991-05-22 Nippon Mining Co Vector de expressao para hirudina, microorganismos transformados e metodos para a producao de hirudina
JPH0376579A (ja) 1989-08-18 1991-04-02 Nippon Mining Co Ltd ヒト‐アンジオジェニン発現ベクター及びヒト‐アンジオジェニンの製造方法
GB9010552D0 (en) * 1990-05-10 1990-07-04 Erba Carlo Spa Method for the recombinant production of hirudins and novel hirudins

Also Published As

Publication number Publication date
CA2072375C (en) 2000-01-11
WO1992008736A1 (fr) 1992-05-29
CA2255396A1 (en) 1992-05-09
GR3029824T3 (en) 1999-06-30
NO982207D0 (no) 1998-05-14
ES2093717T3 (es) 1997-01-01
FI107928B (fi) 2001-10-31
US5516656A (en) 1996-05-14
GR3021410T3 (en) 1997-01-31
FI922963A0 (fi) 1992-06-26
ATE140929T1 (de) 1996-08-15
DE69130872T2 (de) 1999-08-26
DK0511393T3 (da) 1996-12-09
FI922963A (fi) 1992-06-26
DE69130872D1 (de) 1999-03-18
EP0687731A1 (en) 1995-12-20
EP0511393B1 (en) 1996-07-31
AU8846691A (en) 1992-06-11
ES2129749T3 (es) 1999-06-16
AU5470194A (en) 1994-03-24
NO303735B1 (no) 1998-08-24
AU648124B2 (en) 1994-04-14
EP0511393A1 (en) 1992-11-04
DK0687731T3 (da) 1999-09-20
EP0687731B1 (en) 1999-02-03
CA2072375A1 (en) 1992-05-09
DE69121192D1 (de) 1996-09-05
NO982207L (no) 1992-09-07
NO922671D0 (no) 1992-07-07
ATE176500T1 (de) 1999-02-15
US5573929A (en) 1996-11-12
DE69121192T2 (de) 1997-02-20
EP0511393A4 (en) 1993-08-11
AU673870B2 (en) 1996-11-28

Similar Documents

Publication Publication Date Title
NO922671D0 (no) Hirudinanalog, fremgangsmaate for fremstilling derav, antikoagulantpreparat, sekresjonsvektor, transformerte mikroorganismer som inneholder vektoren, og fremgangsmaate for fremstilling av produkter fra mikroorganismen
EP0307592A3 (de) Varianten des pankreatischen Rinder-Trypsininhibitors, deren Herstellung und Verwendung
NO973985D0 (no) Fremgangsmåter og blandinger for sekresjon av heterologe polypeptider
SG59931A1 (en) Stem cell factor
IL94183A (en) cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE
EP0219106A3 (en) Polypeptides that elicit antibodies against aids virus
IL85020A (en) Pancreatic secretory trypsin inhibitor variants, their production, expression vectors and recombinant hosts therefor and pharmaceutical compositions containing them
DE3683267D1 (de) Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung.
ES2017122A6 (es) Procedimiento de preparacion de proteina de ligado de heparina.
ZA916171B (en) Protein structure of the plant toxin gelonin
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
AU3595489A (en) Amblyommin, a new active substance for anticoagulant therapy
EP0300459A3 (en) Human pancreatic secretory trypsin inhibitor
ATE143974T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung
AU4664489A (en) Ancrod proteins, their production and use
AU5110390A (en) Cdna coding for placental protein 9 (pp9), the isolation and use thereof

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees